Hybrid studies, patient-centric tools, and collaborations are driving big changes for clinical trials and stakeholders during the COVID-19 pandemic. In an Applied Clinical Trials article entitled Sharpening the Focus on Patient Centricity as Pandemic Continues, Melissa Nezos, Firma’s VP of Clinical Operations, says sponsors are having Firma look at protocols to bring more virtual clinical trial elements through home visits. She points out that many protocols include assessments and items that could be performed in the home with the help of home health practitioners, such as sample collection, blood draw and EKG.
Read the Applied Clinical Trials article HERE to learn more about what is possible now and in the future for decentralized clinical trials.
